Acquiring Company
Lallemand
Acquired Company
BIO-CAT
Toronto
United StatesBiotechnologyAgriculture and FarmingManufacturingBiotechnologyAgriculture and FarmingHealth CareDescription
Lallemand has announced the acquisition of BIO-CAT, enhancing its U.S. footprint and production capacity. This merger will strengthen Lallemand's capabilities in dietary supplements and health ingredients. With the addition of BIO-CAT's two facilities in Virginia and Minnesota, the combined entity aims to innovate and meet evolving industry needs. The acquisition aligns with both companies' commitment to shared values and sustainable growth.
Quick answer
Lallemand is acquiring BIO-CAT, announced August 4, 2026. Lallemand is based in Toronto, Ontario, Canada.
- How much did Lallemand pay for BIO-CAT?
- The deal value was not disclosed.
- What does Lallemand do?
- Lallemand is a privately held global company focused on the development, production and marketing of yeasts, bacteria, fungi and enzyme-based solutions across various sectors.
- Where are Lallemand and BIO-CAT based?
- Lallemand is based in Toronto, Ontario, Canada. BIO-CAT is based in United States.
- Who are the decision-makers at Lallemand?
- Fundz holds 1 contact at Lallemand. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Agriculture and Farming and Agriculture and Farming
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Curaleaf to acquire Aurora Cannabis for $272 million, $272M (August 16, 2026)
- Aurora Cannabis acquires Internode and HAP Pharma (August 19, 2026)
- OrthoPediatrics acquires SpineCorporation, enhancing reach (July 27, 2026)
- Elanco Animal Health acquires Kindred Biosciences (July 17, 2026)
- Alkem Medtech to acquire majority stake in Occlutech (June 29, 2026)
- Merck KGaA to acquire Bio-Techne Corporation (June 25, 2026)
Who to call at Lallemand, and when
When Lallemand changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Lallemand raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lallemand, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lallemand. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lallemand makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired BIO-CAT?
BIO-CAT was acquired by Lallemand, based in Toronto. The deal was reported on August 4, 2026. Lallemand is a privately held global company focused on the development, production and marketing of yeasts, bacteria, fungi and enzyme-based solutions across various sectors. Lallemand is privately held and operates in Biotechnology.
When did Lallemand acquire BIO-CAT?
Lallemand's acquisition of BIO-CAT was reported on August 4, 2026. Lallemand has announced the acquisition of BIO-CAT, enhancing its U.S. footprint and production capacity. This merger will strengthen Lallemand's capabilities in dietary supplements and health ingredients. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does BIO-CAT do?
BIO-CAT is a pioneer in the wholesale of dietary enzymes and microbial solutions, founded in 1988. The company offers a diverse range of enzyme blends and probiotics. Their products are utilized in various industries such as health, agriculture, and food. It is privately held, operating in Manufacturing, and is based in United States.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.